2017
DOI: 10.1016/j.carrev.2016.10.002
|View full text |Cite
|
Sign up to set email alerts
|

A novel risk model including vascular access site for predicting 30-day mortality after primary PCI: The ALPHA score

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
17
1
3

Year Published

2018
2018
2024
2024

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 14 publications
(22 citation statements)
references
References 23 publications
0
17
1
3
Order By: Relevance
“…Risk stratification in patients with STEMI is a major feature in real clinical practice, as it provides a broad perspective of patient outcomes based on patient characteristics and optimal treatment. In this regard, plenty of clinical risk scores for determining prognosis in STEMI patients, such as the GRACE risk score, TIMI score, PAMI score, Zwolle risk score, CADILLAC score, ALPHA score [14][15][16][17][18][19] have been tested to provide an optimal management. The GRACE risk score is considered the most robust score for evaluating the risk in patients with STEMI/NSTEMI at initial presentation 14 , although it is a classic score which was developed in an era of less effective pharmacological and interventional treatment and it does not consider the impact of the angiographic severity of the disease, the history of peripheral vascular disease and the effect of pulmonary disease on cardiovascular outcomes.…”
Section: Discussionmentioning
confidence: 99%
“…Risk stratification in patients with STEMI is a major feature in real clinical practice, as it provides a broad perspective of patient outcomes based on patient characteristics and optimal treatment. In this regard, plenty of clinical risk scores for determining prognosis in STEMI patients, such as the GRACE risk score, TIMI score, PAMI score, Zwolle risk score, CADILLAC score, ALPHA score [14][15][16][17][18][19] have been tested to provide an optimal management. The GRACE risk score is considered the most robust score for evaluating the risk in patients with STEMI/NSTEMI at initial presentation 14 , although it is a classic score which was developed in an era of less effective pharmacological and interventional treatment and it does not consider the impact of the angiographic severity of the disease, the history of peripheral vascular disease and the effect of pulmonary disease on cardiovascular outcomes.…”
Section: Discussionmentioning
confidence: 99%
“…In the development set of the "Thrombolysis in Myocardial Infarction" (TIMI) risk score, the oldest of the analyzed algorithms (6), and the derivative "Dynamic TIMI" model ( 12) patients were treated with fibrinolysis. In contrast, newer scores used primary PCI (7)(8)(9)(10)(11)13) or PCI (16), depending on the clinical setting, as a treatment modality. Nevertheless, in the AR-G algorithm for STEMI and non STEMI (14) and in the GRACE 2.0 model developed for all types of the ACS (15), the therapeutic modality was not specified.…”
Section: Treatment Modalitymentioning
confidence: 99%
“…Missing or underrepresentation of prognostically important factors in the derivation data set may result in a systematic misestimation of the regression coefficients and biased prediction, limiting the generalizability of the algorithm. Newer models, however, usually employed derivation data from single-or multi-center registries representing "real-world" patients (8,11,(13)(14)(15)(16). Likewise, the risk prediction algorithms were mostly validated using registries (Table 2).…”
Section: Source Of Datamentioning
confidence: 99%
See 1 more Smart Citation
“…A score-ok folyamatos, minden beteg esetén való alkalmazása (tulaj-rehozása) epidemiológiai eszközként felhasználható a ganizációs) összehasonlításhoz, és egyes ellátóhelyen klinikai vizsgálatok tervezésekor az azokba való célzott beválogatáshoz a szükséges minta méretének csök-kentés céljából. Az ST-elevációval járó szívinfarktusos betegek morelmúlt két évtizedben folyamatosan központi téma volt a szakirodalomban, 2000 óta számos algoritmust pub-ben a terápiás modalitások is változtak (trombolízis, perkután koronáriaintervenció (PCI), valamint szekunder prevenciós gyógyszeres terápia), ma az európai és amerikai irányelvek alapján is a primer perkután koronáriaintervenció a választandó terápiás stratégia (12)(13)(14). is viszonylag korán kalkulálhatók.…”
unclassified